Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin 6-month formulation in central precocious puberty
2015-001607-30Phase 3
- Sponsor
- Debiopharm
- Start
- Apr 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of triptorelin in central precocious puberty (CPP), sponsored by Debiopharm. Primary endpoint: Percentage of children with LH suppression to prepubertal levels at Month 6.
02
Drugs
triptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on 2015-001607-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001607-30.